Cyclocurcumin is primarily studied for its potential biological activities, particularly in the field of cancer research. It has shown inhibitory effects on the growth of certain tumor cells, making it a subject of interest in anticancer drug development. Its unique cyclic structure contributes to stability and interaction with cellular targets involved in inflammation and oxidative stress pathways. Cyclocurcumin also exhibits antioxidant properties, which may support its role in protecting cells from damage caused by free radicals. Additionally, it is investigated for its ability to modulate signaling molecules in chronic diseases, including neurodegenerative and inflammatory conditions. Due to its natural origin and low toxicity profile, cyclocurcumin is considered a promising candidate for further exploration in pharmaceutical and nutraceutical applications.